Search results for "Progress"

showing 10 items of 1620 documents

Value of serial magnetic resonance imaging in the assessment of brain metastases volume control during stereotactic radiosurgery

2016

AIM To evaluate brain metastases volume control capabilities of stereotactic radiosurgery (SRS) through serial magnetic resonance (MR) imaging follow-up. METHODS MR examinations of 54 brain metastases in 31 patients before and after SRS were reviewed. Patients were included in this study if they had a pre-treatment MR examination and serial follow-up MR examinations at 6 wk, 9 wk, 12 wk, and 12 mo after SRS. The metastasis volume change was categorized at each follow-up as increased (> 20% of the initial volume), stable (± 20% of the initial volume) or decreased (< 20% of the initial volume). RESULTS A local tumor control with a significant (P < 0.05) volume decrease was observed in 25 meta…

medicine.medical_specialtyPseudo progressionBrain metastasemedicine.medical_treatmentPseudo-progressionVolume controlRadiosurgery03 medical and health sciencesMagnetic resonance imaging0302 clinical medicineRetrospective StudymedicineStereotactic radiosurgerymedicine.diagnostic_testbusiness.industryBrain metastasesMagnetic resonance imagingequipment and suppliesRadiation therapyRadiation therapySerial magnetic resonance imaging030220 oncology & carcinogenesisRadiologyNuclear medicinebusinesshuman activities030217 neurology & neurosurgeryWorld Journal of Radiology
researchProduct

Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw - Prognostic factors in the treatment of BRONJ -

2014

Objectives: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a relatively rare but serious side effect of bisphosphonate (BP)-based treatments. This retrospective study aimed to investigate the risk factors and predictive markers in cases where patients were refractory to a recommended conservative treatment offered in our hospital. Patients and Methods: This single-center study collated the medical records of all patients treated for BRONJ between 2004 and 2011. A complete medical history, including detailed questionnaires, was collected for all patients, focusing on identifying underlying risk factors, clinical features, location and bone marker levels of BRONJ. Results: The mea…

medicine.medical_specialtySide effectbusiness.industryMedical recordmedicine.medical_treatmentResearchRetrospective cohort studyOdontologíaBisphosphonatemedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryN-terminal telopeptideInternal medicineUNESCO::CIENCIAS MÉDICASMedicineMedical historyOral SurgerybusinessOsteonecrosis of the jawGeneral DentistryProgressive disease
researchProduct

The influence of the C1-inhibitor BERINERT® and the protein-free haemodialysate ACTIHAEMYL20%® on the evolution of the depth of scald burns in a porc…

1997

Standardized deep partial-thickness burns were inflicted on domestic pigs by scalding 30 per cent of the skin surface for 25 s with 75 degrees C hot water. The animals (n = 18; weight 25-35 kg) were divided into three groups: I, control group (n = 6), Ringer's lactate only; II, haemodialysate group (n = 6), Ringer's lactate and a protein-free haemodialysate of calf-blood (ACTIHAEMYL20%; AH) and III, C1-inhibitor group (n = 6), Ringer's lactate and C1-inhibitor (C1-INH; BERINERT). Skin biopsies were taken at defined time points (4, 28, 52 and 76 h) and investigated histologically. Depth of burn was determined morphometrically after coloration with a modified MTT-staining on frozen sections o…

medicine.medical_specialtySwineComplement C1 Inactivator ProteinsCritical Care and Intensive Care MedicineStatistics NonparametricMicrocirculationC1-inhibitorRandom AllocationReference ValuesBiopsySkin surfacemedicineScaldingAnimalsSkinWound Healingmedicine.diagnostic_testbiologybusiness.industryBiopsy NeedleHistologyGeneral Medicinemedicine.diseaseSurgeryDisease Models AnimalProtein freeAnesthesiaDisease ProgressionEmergency Medicinebiology.proteinActihaemylSurgeryBurnsWound healingbusinessComplement C1 Inhibitor ProteinBurns
researchProduct

The challenge of the volume status assessment in heart failure.

2009

medicine.medical_specialtySystoleBlood volumeDoppler echocardiographyVentricular Dysfunction LeftInternal medicinemedicineIntravascular volume statusVentricular PressureHumansSystoleHeart FailureBlood Volumemedicine.diagnostic_testbusiness.industryDisease progressionmedicine.diseasePrognosisEchocardiography DopplerHeart failureCardiologyVentricular pressureheart failure volume status assessmentDisease ProgressionCardiology and Cardiovascular MedicinebusinessAmerican heart journal
researchProduct

Predictors of Progression in Hypertensive Renal Disease in Children

2004

In hypertensive renal disease in children, several risk factors influence the development and the rate of progression of renal damage, including blood pressure levels, proteinuria, lipid disorders, and genetic differences. The impact of blood pressure on renal structures, the most important of the factors, depends not only on blood pressure levels, but also on the persistence of the blood pressure levels over time, mainly during the hours when the patient is resting or sleeping. Abnormal circadian variability is frequently observed in patients with renal damage, and nocturnal blood pressure reduction should be a major therapeutic objective to protect against a decline in renal function. Pro…

medicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismRenal functionDiseaseurologic and male genital diseasesRisk FactorsInternal medicineInternal MedicineHumansMedicineIn patientCircadian rhythmChildReview PaperProteinuriabusiness.industryRenal damageAge FactorsPrognosisNocturnal blood pressureProteinuriaBlood pressureEndocrinologyHypertensionDisease ProgressionCardiologyKidney Diseasesmedicine.symptomCardiology and Cardiovascular MedicinebusinessThe Journal of Clinical Hypertension
researchProduct

Improved Safety with the Use of Subcutaneous Bortezomib in Combination with Panobinostat and Dexamethasone: Preliminary Data from a Panobinostat Glob…

2016

Abstract Introduction: Panobinostat (PAN) is a potent pan-deacetylase inhibitor that targets multiple myeloma (MM) cells via its epigenetic effects as well as its effect on the aggresome. In the PANORAMA 1 phase 3 trial, the combination of PAN, bortezomib (BTZ), and dexamethasone (Dex; PAN+BTZ+Dex) significantly increased progression-free survival compared with placebo plus BTZ and Dex, leading to approval in Europe of the combination for the treatment of patients with MM who have received ≥ 2 prior regimens, including BTZ and an immunomodulatory agent. The purpose of this expanded treatment protocol (ETP) is to further evaluate safety and to provide panobinostat prior to commercial availab…

medicine.medical_specialtyTreatment protocolBortezomibbusiness.industryImmunologyDisease progressionCell BiologyHematologyNeutropeniamedicine.diseaseBiochemistryOlder populationSurgerychemistry.chemical_compoundchemistryTolerabilityInternal medicinePanobinostatmedicinebusinessDexamethasonemedicine.drugBlood
researchProduct

ICUD-EAU International Consultation on Bladder Cancer 2012: Non–Muscle-Invasive Urothelial Carcinoma of the Bladder

2012

Item does not contain fulltext CONTEXT: Our aim was to present a summary of the Second International Consultation on Bladder Cancer recommendations on the diagnosis and treatment options for non-muscle-invasive urothelial cancer of the bladder (NMIBC) using an evidence-based approach. OBJECTIVE: To critically review the recent data on the management of NMIBC to arrive at a general consensus. EVIDENCE ACQUISITION: A detailed Medline analysis was performed for original articles addressing the treatment of NMIBC with regard to diagnosis, surgery, intravesical chemotherapy, and follow-up. Proceedings from the last 5 yr of major conferences were also searched. EVIDENCE SYNTHESIS: The major findi…

medicine.medical_specialtyUrologymedicine.medical_treatmentUrologyMEDLINEAntineoplastic AgentsContext (language use)Aetiology screening and detection [ONCOL 5]CystectomyQuality of Care [ONCOL 4]Molecular epidemiology [NCEBP 1]CystectomyTranslational research [ONCOL 3]medicineHumansNeoplasm InvasivenessProspective cohort studyNeoplasm StagingBladder cancermedicine.diagnostic_testbusiness.industryGeneral surgeryCarcinoma in situCystoscopymedicine.diseaseAdministration IntravesicalTreatment OutcomeUrinary Bladder NeoplasmsBCG VaccineDisease ProgressionNeoplasm GradingNeoplasm Recurrence LocalUrotheliumbusinessIntravesical chemotherapyCarcinoma in SituEuropean Urology
researchProduct

Substance P is upregulated in the serum of patients with chronic spontaneous urticaria.

2014

medicine.medical_specialtyUrticariaMEDLINESubstance PDermatologyAnxietySubstance PBiochemistrySeverity of Illness Indexchemistry.chemical_compoundText miningQuality of lifeDownregulation and upregulationInternal medicineGermanySeverity of illnessMedicineHumansMolecular Biologybusiness.industryDepressionDisease progressionCell BiologyUp-RegulationMulticenter studychemistryChronic DiseaseDisease ProgressionQuality of LifebusinessBiomarkersThe Journal of investigative dermatology
researchProduct

SVC Is a Marker of Respiratory Decline Function, Similar to FVC, in Patients With ALS

2019

Copyright © 2019 Pinto and de Carvalho. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

medicine.medical_specialtyVital capacityPrognostic variableamyotrophic lateral sclerosisNeurologyNeurologipredictorlcsh:RC346-429functional outcome03 medical and health sciencesFEV1/FVC ratioslow vital capacity0302 clinical medicineInternal medicinemedicineRespiratory function030212 general & internal medicineAmyotrophic lateral sclerosisRespiratory systemlcsh:Neurology. Diseases of the nervous systembusiness.industryProportional hazards modelNeurosciencesBrief Research Reportmedicine.diseaseNeurologyCardiologyrate of progressionNeurology (clinical)business030217 neurology & neurosurgeryNeurovetenskaperFrontiers in Neurology
researchProduct

Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS ≤ 3.5

2003

Objectives – Previous papers have mainly demonstrated the presence and the frequency of cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis. The purpose of this study was to investigate subjects with the relapsing-remitting form of the disease and mild clinical disability (EDSS ≤ 3.5), so as to quantify this deficit when the illness does not yet interfere with daily living and the ability to work. Methods – Fifty patients and 50 healthy controls were submitted to a wide neuropsychological battery, including Wechsler Memory Scale – I- (WMS), Benton Visual Retention Test – D- (BVRT), Raven Coloured Progressive Matrices (RCPM), Kohs’ test (KT), Judgement of L…

medicine.medical_specialtyWechsler Memory Scalemedicine.diagnostic_testCognitive disorderCognitionNeurological examinationGeneral MedicineAudiologymedicine.diseaseBenton Visual Retention TestRaven's Progressive MatricesNeurologymedicineMemory impairmentNeurology (clinical)Cognitive declinePsychiatryPsychologyActa Neurologica Scandinavica
researchProduct